← Open Payments lookup

ROBERT SEWARD: Open Payments

NPI 1063402600 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,405 in 131 payments from 20 companies in 2025. Trend: 2023 $2,420 · 2024 $2,735 · 2025 $2,405

Food & beverage: $2,405
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.18$373
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$307
Neurocrine BioSciences, Inc.13$307
ABBVIE INC.21$230
E.R. Squibb & Sons, L.L.C.9$175
Axsome Therapeutics, Inc.6$136
Janssen Pharmaceuticals, Inc4$120
Alkermes, Inc.5$109
Lundbeck LLC5$101
Takeda Pharmaceuticals U.S.A., Inc.5$93

Products named: CAPLYTA, INGREZZA, FANAPT, VRAYLAR, COBENFY, Auvelity, REXULTI, ARISTADA.

Industry payments across VA — which companies pay providers there.